Amber Therapeutics is a UK-based medical technology startup developing novel adaptive neuromodulation therapy known as Amber-UI for treating women suffering from mixed urinary incontinence (MUI). Founded in 2020, the company has its headquarters in London, United Kingdom.
read more..